Hepatology International : Impact Factor & More
eISSN: 1936-0541pISSN: 1936-0533
Share this on:
Key Metrics
CiteScore 
8.9
Eigenfactor
0.005 - 0.01
H-Index
58
Impact Factor
5 - 10
SJR
Q1Hepatology
SNIP
1.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Hepatology International
Hepatology International Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Hepatology International ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hepatology International
Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease.
- 19 May 2026
- Hepatology international
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
- 13 May 2026
- Hepatology international
New therapies for primary biliary cholangitis.
- 8 May 2026
- Hepatology international
Low lysosomal acid lipase activity is associated with histological progression of metabolic dysfunction-associated steatotic liver disease.
- 22 Apr 2026
- Hepatology international
Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis.
- 21 Apr 2026
- Hepatology international
Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma?
- 19 Apr 2026
- Hepatology international
Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease.
- 19 May 2026
- Hepatology international
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.
- 13 May 2026
- Hepatology international
New therapies for primary biliary cholangitis.
- 8 May 2026
- Hepatology international
Low lysosomal acid lipase activity is associated with histological progression of metabolic dysfunction-associated steatotic liver disease.
- 22 Apr 2026
- Hepatology international
Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis.
- 21 Apr 2026
- Hepatology international
Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma?
- 19 Apr 2026
- Hepatology international
FAQs on Hepatology International
How long has Hepatology International been actively publishing? 
What is the publishing frequency of Hepatology International?
How many articles did Hepatology International publish last year?
What is the eISSN & pISSN for Hepatology International?
What is Citescore for Hepatology International?
What is the H Index for Hepatology International ?
What is SNIP score for Hepatology International?
What is the SJR for Hepatology International?
Who is the publisher of Hepatology International?
